Attached files

file filename
EX-99.1 - EXHIBIT 99.1 - HANSEN MEDICAL INCexh99_1.htm
 


 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
 
 

 
FORM 8-K
 

 
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D)
OF THE SECURITIES AND EXCHANGE ACT OF 1934
 
Date of report (Date of earliest event reported): August 7, 2013
 

 
HANSEN MEDICAL, INC.
(Exact name of registrant as specified in charter)
 

 

 
         
Delaware
 
001-33151
 
14-1850535
(State or other jurisdiction
of incorporation)
 
(Commission
File Number)
 
(I.R.S. Employer
Identification No.)
 
800 East Middlefield Road
Mountain View, California 94043
(Address of principal executive offices and zip code)
 
Registrant’s telephone number, including area code: (650) 404-5800
 
 
 

 

 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
¨
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
¨
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
¨
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
¨
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
 
 
 

 
Item 2.02. Results of Operations and Financial Condition.
 
On August 7, 2013, Hansen Medical, Inc. issued a press release announcing second quarter and six-month 2013 financial results. A copy of the press release is attached as Exhibit 99.1 to this current report and is incorporated herein by reference.
 
The information in this current report and in the accompanying exhibit shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended. The information contained in this current report and in the accompanying exhibit shall not be incorporated by reference into any filing with the U.S. Securities and Exchange Commission made by Hansen Medical, Inc, whether made before or after the date hereof, regardless of any general incorporation language in such filing.
 
Item  9.01. Financial Statements and Exhibits.
 
(d) Exhibits.
 
     
Exhibit
No.
  
Description
   
  
Press release, dated August 7, 2013, entitled “Hansen Medical Reports Second Quarter and Six-Month 2013 Results”.


 
 

 


SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
 
             
       
HANSEN MEDICAL, INC.
(Registrant)
     
Date: August 7, 2013
     
/s/ PETER J. MARIANI                                 
       
Peter J. Mariani
       
Chief Financial Officer